ANALYSIS OF THE ASSOCIATIONS OF GENE POLYMORPHISMS WITH POLYCYSTIC OVARY SYNDROME AND ENDOCRINE AND METABOLIC DISTURBANCES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Ministry of Health and Social Development of Russia, Moscow 2Research Institute of Physicochemical Medicine, Federal Biomedical Agency, Moscow Objective. To search for molecular genetic factors involved in the development of endocrine and metabolic disturbances in polycystic ovary syndrome (PCOS), which may contribute to the clarification of the pathogenetic mechanisms of development of the disease. Subjects and methods. A study group included 98 women with verified PCOS; a comparison group (without PCOS) comprised 62 patients with tuboperitoneal and male factors of infertility. The investigators employed molecular genetic studies, such as polymerase chain reaction, minisequencing, agarose gel electrophoresis, and mass spectrometry. SGTA, FST, IRS1, IRS2, PPARg, HSD17B5, HSD17B6, FTO, FEM1B, and FEM1A gene polymorphisms were analyzed. Results. The carriage of either the minor allele T of the IRS2 and IRS1 genes in the heterozygous state or the homozygous genotype TT involves a three- to ten-fold risk for PCOS. That of the minor allele T of the IRS2 gene determines a double risk for higher HOMA scores and a trend risk for glucose intolerance. The homozygous genotype CC of the IRS1 gene produces a protective effect against the risk for glucose intolerance in the presence of PCOS. The carriage of the homozygous genotype TT of the IRS1 gene is associated with a five-fold risk for increased HOMA scores. In minor allele A carriage, HSD17B6 gene polymorphism was ascertained to involve a three-fold risk for higher HOMA scores and the carriage of the homozygous genotype GG determined its protective effect against the same sign. HSD17B5 gene polymorphism was responsible for a two-fold risk for increased HOMA scores with minor allele A carriage. Investigation of the other (FST, FTO, FEM1A, FEM1B, PPARg, and SGTA) gene polymorphisms in question revealed no signif icant associations either in the PCOS group or the comparison one. Conclusion. The molecular genetic study has revealed associations of the gene polymorphisms with the risk for just PCOS and its metabolic symptoms.

Full Text

Restricted Access

About the authors

G. T SUKHIKH

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: g_sukhikh@oparina.ru

A. M BIRYUKOVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

T. A NAZARENKO

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

N. B ZAKHARZHEVSKAYA

Research Institute of Physicochemical Medicine, Federal Biomedical Agency

E. R DURINYAN

Research Institute of Physicochemical Medicine, Federal Biomedical Agency

E. V GENEROZOV

Research Institute of Physicochemical Medicine, Federal Biomedical Agency

V. M GOVORUN

Research Institute of Physicochemical Medicine, Federal Biomedical Agency

References

  1. Андреева Е.Н., Семичева Т.В., Веснина А.Ф. и др. Молекулярно-генетические аспекты патогенеза СПКЯ // Пробл. репрод. - 2007. — Т. 13, № 6. — С. 29—35.
  2. Андреева Е.Н., Веснина А.Ф., Семичева Т.В. и др. Особенности клинических проявлений СПКЯ у больных с полиморфизмом в гене инсулина INS V NTP // Пробл. репрод. — 2008. — № 1. — С.
  3. Веснина А.Ф., Андреева Е.Н., Семичева Т.В. Особенности углеводного обмена и чувствительности к инсулину у больных при генотипических отличиях по полиморфизму// Репродуктивное здоровье семьи: Материалы 2-го Международного конгресса по репродуктивной медицине. — М., 2008.
  4. Дедов И.И., Мельниченко Г.А. Синдром поликистозных яичников: Руководство для врачей— М.: МИА, 2007.
  5. Сухих Г.Т., Бирюкова А.М., Назаренко Т.А., Дуринян Э.Р. Эндокринно-метаболические особенности у пациенток с синдромом поликистозных яичников// Акуш. и гин. — 2011. — № 4 — С. 45—49.
  6. Amato P., Simpson J.L. The genetics of polycystic ovary syndrome // Best. Pract. Res. Clin. Obstet. Gynaecol. -2005. - Vol. 18. - Р. 707-718.
  7. Diamanti-Kandarakis E., Piperi C. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth // Hum. Reprod. Update. — 2005. — Vol. 11. — Р. 631-643.
  8. Ehrmann D.A. Polycystic ovary syndrome// N. Engl. J. Med. — 2005. — Vol. 352. — Р.1223-1236.
  9. Ehrmann D.A., Tang X., Yoshiuchi I. et al. Relationship of insulin receptor substrate-1 and 2 genotypes to phenotypic features of polycystic ovary syndrome.// J. Clin. Endocrinol. Metab. - 2002. - Vol. 87. - Р. 4297- 4300.
  10. El Mkadem S.A., Lautier C., Macari F. et al. Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to severe insulin resistance of women with polycystic ovary syndrome // Diabetes. - 2001. - Vol. 50. -Р. 2164-2168.
  11. Jahanfar S., Eden J.A. Genetic and non-genetic theories on the etiology of polycystic ovary syndrome // Gynecol. Endocrinol. - 1996. - Vol. 10. - Р. 357-364.
  12. Nobels F., Dewailly D. Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis // Fertility and Sterility. - 1992. — Vol. 58, № 4. — Р. 655—666.
  13. Qin K., Ehrmann D.A., Cox N. et al. Identification of functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome // J. Clin. Endocrinol. Metab. — 2006. - Vol. 91, № 1. - Р. 270—276.
  14. Roeder K., Bacanu S.A., Wasserman L., Devlin B. Using linkage genome scans to improve power of association in genome scans // Am. J. Hum. Genet. — 2006. — Vol. 78. — Р. 243-252.
  15. Sir-Petermann T., Perez-Bravo F., Angel B. et al. G972R polymorphism of IRS-1 in women with polycystic ovary syndrome // Diabetologia. - 2001. -Vol. 44. - Р. 12001201.
  16. Villuendas G., Botella-Carretero J.I., Roldan B. et al. Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls// Hum. Reprod. - 2005. -Vol. 20. - Р. 3184-3191.
  17. Wu X.K., Zhou S.Y., Liu J.X. et al. Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome// Fertil. and Steril. — 2003. — Vol. 80, № 4. — Р. 954-965.
  18. Zacur H.A. Polycystic ovary syndrome, hyperandrogenism, and insulin resistance// Obstet. Gynecol. Clin. — 2001. — Vol. 28, № 1. — Р. 21—33.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies